Valuation (78%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 9.98 | N/A |
| PEG Ratio (TTM) | -0.55 | N/A |
| P/S Ratio (TTM) | 3.56 | N/A |
| P/B Ratio (TTM) | 0.69 | N/A |
| P/FCF Ratio (TTM) | 8.78 | N/A |
| Price to 5YR AVG Earnings Ratio | 7.69 | N/A |
| Price to 5YR AVG FCF Ratio | 3.74 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.88% | N/A |
| ROE (TTM) | 6.93% | N/A |
| Net Profit Margin (TTM) | 35.23% | N/A |
| ROIC 5YR AVG | 4.55% | N/A |
Growth (83%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -17.98% | 144.74% | 82.81% |
| Revenue | 11.41% | 128.31% | 80.02% |
| Net Income | -17.29% | 146.52% | 88.94% |
| Cash Flow | 27.52% | 430.23% | 571.92% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.34 | N/A |
| Quick Ratio (TTM) | 0.34 | N/A |
| D/E Ratio (TTM) | 0.93 | N/A |
| Interest Coverage (TTM) | 1.08 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 0.40 | N/A |
| LTL to 5YR AVG FCF | 8.97 | N/A |
| Shares Outstanding Growth 5YR AVG | 8.01% | N/A |